An experimental drug called solanezumab has demonstrated the potential to slow cognitive decline in patients with mild cases of Alzheimer’s disease. NBC’s Robert Bazell reports.Oct. 9, 2012
UP NEXT
Fire at oil tank farm prompts evacuation orders in Louisiana
00:48
Nightly News Full Broadcast (June 3rd)
21:33
Teen and friends shave their heads to support mother battling cancer
02:51
New technology creates AI romantic partners for users
03:15
Parts of Florida under flood alert as Arlene brings heavy wind and rain
01:32
Federal judge declares Tennessee drag restriction law unconstitutional